Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Edgewise Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Edgewise Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights"
07/14/2023 8-K Quarterly results
06/16/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits...
Docs: "Common stock SALES AGREEMENT",
"Re: Registration Statement on Form S-3"
05/11/2023 8-K Quarterly results
Docs: "Edgewise Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights"
03/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Edgewise Therapeutics Appoints Industry Veteran Jonathan C. Fox, M.D., Ph.D., FACC to its Board of Directors"
02/23/2023 8-K Quarterly results
Docs: "Edgewise Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights"
11/03/2022 8-K Quarterly results
09/14/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNDERWRITING AGREEMENT",
"Follow-On Public Offering of Edgewise Therapeutics, Inc."
09/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investors & Media",
"Investors & Media",
"Updated Risk Factor Disclosure"
08/04/2022 8-K Quarterly results
Docs: "Edgewise Therapeutics Reports Second Quarter 2022 Financial Results"
06/24/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
01/05/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Edgewise Therapeutics Announces Positive Topline Results From the EDG-5506 Phase 1b Clinical Trial in Adults With Becker Muscular Dystrophy"
11/10/2021 8-K Quarterly results
Docs: "Edgewise Therapeutics Reports Third Quarter 2021 Financial Results"
10/28/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Edgewise Therapeutics Announces Positive Topline Results from the EDG-5506 Phase 1 Multiple Ascending Dose Study in Healthy Volunteers and Doses First Becker Muscular Dystrophy Patients"
08/09/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/30/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "Amended and Restated Certificate of Incorporation of the Registrant",
"Amended and Restated Bylaws of the Registrant",
"Press Release"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy